Sbi Securities Co., Ltd. Chemomab Therapeutics Ltd. Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Chemomab Therapeutics Ltd. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 100 shares of CMMB stock, worth $208. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100Holding current value
$208% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CMMB
# of Institutions
19Shares Held
4.5MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA1.74MShares$3.62 Million0.06% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L31.21MShares$2.53 Million0.35% of portfolio
-
Yelin Lapidot Holdings Management Ltd. Tel Aviv, L3744KShares$1.55 Million0.23% of portfolio
-
Morgan Stanley New York, NY402KShares$836,7250.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX213KShares$443,8550.06% of portfolio
About Chemomab Therapeutics Ltd.
- Ticker CMMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,431,700
- Market Cap $23.8M
- Description
- Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (...